David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 17,020 shares at $89.98 ($1.5M) on 2023-07-03, disclosed to the SEC on 2023-07-06.
Scheduled sale ($1.5M) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.98 | 8,510 | $766K | 50.0% |
| 2 | $89.98 | 8,510 | $766K | 50.0% |
| Total | $89.98 avg | 17,020 | $1.5M | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |